compounded tirzepatide news Compound Tirzepatide: All Eyes on December 19th Eli Lilly sues companies selling

### Step 5: Do Not Shake Gently Swirl or Roll Shaking causes peptide aggregation and can degrade retatrutide

Leading GLP-1s expected to reach $50B in 2025 sales Novos Ozempic expected to retain top spot, with similarly large growth rates anticipated for Novos Wegovy and Lillys tirzepatide franchises By the end of 2025, consensus analyst estimates peg the combined sales of the four leading GLP-1 therapies, two apiece from Novo Nordisk and Eli Lilly, at about $50 billion

Subscribe to Propst Metabolic Health & Healthspan for evidence-based discussions of muscle, metabolism, obesity treatment, exercise, and healthy aging

Schedule a consultation with Heally today to discuss your tirzepatide treatment and develop a plan to manage any side effects effectively